Bionano Genomics Inc (NAS:BNGO)
$ 0.904 -0.026 (-2.8%) Market Cap: 62.47 Mil Enterprise Value: 49.37 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Q4 2020 Bionano Genomics Inc Earnings Call Transcript

Mar 23, 2021 / 08:30PM GMT
Release Date Price: $83.7 (-7.51%)
Operator

Good day, and welcome to the Bionano Genomics Fourth Quarter and Year-End 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

At this time, I would like to turn the conference over to Amy Conrad, Investor Relations for Bionano. Amy, please proceed.

Amy Conrad

Thank you, Hilary, and good afternoon, everyone. Welcome to the Bionano Genomics Fourth Quarter and Year-End 2020 Financial Results Conference Call. With me today are Dr. Erik Holmlin, CEO of Bionano; and Chris Stewart, CFO of Bionano. After market close today, Bionano issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2020. A copy of the release can be found on the Investor Relations page of the company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about Bionano's business strategy and commercialization plans, sales pipeline, anticipated benefits or improvements to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot